Diagnostic journeys in myeloma (DJiM) – why are they so long, and what interventions may facilitate earlier diagnosis?



Principal Investigator
Tania Seale (Bangor University)

Neal RD, Kennedy L, Fegan C

Type of study
Surveys of patients, GP’s & consultants. Qualitative interviews.

Myeloma is a rare malignancy of plasma cells, one of the cells of the immune system. Myeloma causes bony complications, anaemia, renal failure and increased susceptibility to infection. It is more common in the elderly and approximately 250 new cases are diagnosed in Wales each year. There is often a long delay between presentation and diagnosis in myeloma compared with other cancers. Existing research into the reasons for this is scanty, but theories include the non-specific nature of symptoms, the rarity of the condition and the lack of knowledge of the disease amongst general practitioners (GPs). Earlier diagnosis of myeloma has the potential to prevent complications developing and allows patients to be fit to receive treatment resulting in better outcomes.

Link with RDG / CSG or similiar
North Wales Centre for Primary Care Research

Start date
Oct 2013

End date
Sep 2016